Furthermore, JAG1-NOTCH4 perception of perturbed flow was shown to enhance atherosclerosis susceptibility by modulating endothelial cell heterogeneity, and therapeutic targeting of this pathway may treat atherosclerosis.88 The gene discussed is JAG1; the disease is atherosclerosis.